Chikungunya Treatment Market Outlook 2020: Opportunity and Growth Analysis - Dominated By Themis Bioscience GmbH, Arno Therapeutics, Inc, Bharat Biotech
Get Sample Report + All Related Graphs & Charts @
Global chikungunya treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of chikungunya treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Definition: Global Chikungunya Treatment Market
Chikungunya virus infection is also known as chikungunya fever is characterized by mosquito-borne viral disease which is spread by a bite of an infected Aedes species mosquito including aedes aegypti and aedes albopictus. The most common symptoms of infection are fever and joint pain.
According to statistics published in the WHO, it was estimated a total of 349,936 suspected and 146,914 laboratory confirmed cases of chikungunya has been reported to the PAHO regional office. Of these, 265, 000 suspected cases were locally reported from the Brazil. The market growth is increased by introduction of novel therapies and rise in government initiatives may increase the chikungunya virus infection drug market.
Increasing prevalence of chikungunya in tropical and sub-tropical regions is driving the market growth.
Increased government funding to fight against chikungunya is accelerating the market growth
Promising chikungunya pipeline is expected to drive the market growth
Demand of novel therapies for treating chikungunya virus infections is also acting as a driver for the market
Lack or insufficient healthcare infrastructure in underdeveloped and developing regions is hampering the market growth
Lack of awareness related to symptoms of chikungunya is hindering the market growth
High cost of the treatment is restraining the market growth.
Segmentation: Global Chikungunya Treatment Market
By Strain Type
By Drug Class
By Route of Administration
By Distribution Channel
Grab Your Report at an Impressive 30% Discount! Please click Here @
Key Developments in the Market
In February 2019, Moderna, Inc, has initiated first dose in patients in a phase I clinical trial for mRNA-1944, an anti-Chikungunya antibody for the treatment of chikungunya virus infections. The dosing of first monoclonal antibody encoded by mRNA in human subject is a significant milestone for a company and represents advances in the novel treatment through targeted mode of action.
In February 2019, Themis Bioscience GmbH received the fast track designation from the FDA for MV-CHIK, a vaccine for the treatment of chikungunya viral infections. The Fast Track designation for MV-CHIK accelerates the review timeline and enhances the attraction with the FDA so that lead candidate can reach the market expeditiously.
In September 2016, Takeda Pharmaceutical Company Limited entered into research collaboration with Zydus Cadila to develop a novel vaccine for the treatment of chikungunya virus infection. This collaboration will address the urgent and neglected unmet medical need as well as expedite the access to novel treatment options for patients suffering from chikungunya.
Reasons to Purchase this Report:
Current and future of global chikungunya treatment market outlook in the developed and emerging markets.
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chikungunya Treatment Market Outlook 2020: Opportunity and Growth Analysis - Dominated By Themis Bioscience GmbH, Arno Therapeutics, Inc, Bharat Biotech here
News-ID: 1970602 • Views: 205
More Releases from Data Bridge Market Research
Global STD Diagnostics Market is Thriving with Rising Latest Trends by 2027 | To â€¦
Global STD Diagnostics Market By Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing), Testing (Laboratory Devices, Point of Care Devices), Testing Devices (Thermal Cyclers , PCR, Lateral Flow Readers - Immunochromatographic assays, Flow Cytometers, Differential Light Scattering machines, Absorbance Microplate Reader, Phone chips, Rapid Diagnostic Kits), End- User (Hospitals, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East
Micro-Hospitals Industry 2020 Market Size, Growth, Revenue, Global Statistics an â€¦
Micro-Hospitals Industry 2020 Market Report provides in-depth analysis including current Micro-Hospitals industry by market dynamics and New Project Feasibility of the market. This report mainly elaborates on market status, competitive landscape, and SWOT Analysis for Micro-Hospitals market worldwide. The report starts with a basic Micro-Hospitals market overview. It also acts as a vital tool to industries active across the value chain and for new entrants by enabling them to take
Global Women's Health Market Future Growth Analysis, Business Demand and Opportu â€¦
In this Global Women's Health Market industry analysis report, several aspects of the market research and analysis for the industry have been underlined. By understanding that the market is regarded as the heart of the economy, this report is prepared on the basis of the ever-changing behavior of market to make it the best one. A competent data and brilliant forecasting techniques used in this report are synonymous with accurateness
Viral Clearance Market 2020 Competitive Insights, Trends and Demand Growth to 20 â€¦
Viral clearance is stated as the removal of contaminated viral by chromatography technique. The development process for monoclonal antibodies, blood-derived product, glycoprotein, and recombinant protein. To ensure that therapeutic drugs derived from certain sources are fully rid of any viral contamination, these protein solutions undergo viral clearance to inactivate or remove viral materials. Viral Clearance Market is expected to rise from its initial estimated value of USD 517million in 2016 to
More Releases for Chikungunya
Chikungunya Fever Global Clinical Trials Review, H2, 2018: Researchmoz.us
Researchmoz added Most up-to-date research on "Chikungunya Fever Global Clinical Trials Review, H2, 2018" to its huge collection of research reports. An insight on the important factors and trends influencing the market. Latest clinical trial report, Chikungunya Fever Global Clinical Trials Review, H2, 2018" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview
Chikungunya Fever Market Segmentation 2018 with Recent Trend by 2023
Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is
Chikungunya Fever Market Worldwide Segmentation with Top Key Merchant â€“ Avail â€¦
The Worldwide Chikungunya Fever Market Research Reports Avail to Market Research Future. The Report Provides Detail Information about and Strategies used by Top Key Players in the Industry. Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected
Chikungunya Fever Diagnosis, treatments and Global Key players 2017
Chikungunya Fever SummaryÂ Clinical trial report, â€œChikungunya Fever Global Clinical Trials Review, H1, 2017" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,
Chikungunya Fever Business Trends That Will Drive Success In 2023
The study report Global Chikungunya Fever Market covers the market analysis for the regions - North America, Europe, Asia Pacific/ Southeast Asia and RoW and country analysis of China, Japan, and India focusing on top manufacturers in global market and the market share they hold including their contribution to the market growth The Chikungunya Fever Market is expected to grow at CAGR 5.86% during forecast period. Top key players for
Chikungunya Fever Market Global Analysis Research Reports 2023
The Analysis presents the study of Global Chikungunya Fever Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold The Chikungunya Fever Market is expected to grow at CAGR 5.86% during forecast period. Chikungunya is a mosquito borne viral disease caused by the RNA virus belonging to the alphavirus genus of family Togaviridae. Chikungunya fever has been reported in